Lysozyme in breast milk is a selection factor for bifidobacterial colonisation in the infant intestine

Beneficial Microbes

Volumn 7, Issue 1, 2016, Pages 53-60

  Minami, J ^a   Odamaki, T ^a   Hashikura, N ^a   Abe, F ^a   Xiao, J Z ^a  

^a MORINAGA MILK INDUSTRY CO LTD   (Japan)

Author keywords

Bifidobacterium; Human breast milk; Lysozyme; Oligosaccharides

Indexed keywords

EGG WHITE; LYSOZYME; PROBIOTIC AGENT;

ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL STRAIN; BIFIDOBACTERIUM; BIFIDOBACTERIUM ADOLESCENTIS; BIFIDOBACTERIUM ANGULATUM; BIFIDOBACTERIUM ANIMALIS SUBSP ANIMALIS; BIFIDOBACTERIUM ANIMALIS SUBSP LACTIS; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM DENTIUM; BIFIDOBACTERIUM INFANTIS; BIFIDOBACTERIUM LONGUM; BIFIDOBACTERIUM PSEUDOCATENULATUM; BIFIDOBACTERIUM PSEUDOLONGUM SUBSP GLOBOSUM; BIFIDOBACTERIUM PSEUDOLONGUM SUBSP PSEUDOLONGUM; BIFIDOBACTERIUM THERMOPHILUM; BREAST MILK; CELL COUNT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; INCUBATION TIME; INFANT; INTESTINE; TAXON; ANIMAL; CHEMISTRY; FECES; FEMALE; GROWTH, DEVELOPMENT AND AGING; INTESTINE FLORA; MICROBIOLOGY;

ADULT; ANIMALS; BIFIDOBACTERIUM; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; INFANT; MILK, HUMAN; MURAMIDASE; PROBIOTICS;

EID: 84958167542     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2015.0041     Document Type: Article

References (33)

1. Asakuma, S., Urashima, T., Akahori, M., Obayashi, H., Nakamura, T., Kimura, K. and Sanai, Y., 2008. Variation of major neutral oligosaccharides levels in human colostrum. European Journal of Clinical Nutrition 62: 488-494.
2. Benno, Y., Endo, K., Mizutani, T., Namba, Y., Komori, T. and Mitsuoka, T., 1989. Comparison of fecal microflora of elderly persons in rural and urban areas of Japan. Applied and Environmental Microbiology 55: 1100-1105.
3. Boesten, R., Schuren, F., Ben Amor, K., Haarman, M., Knol, J. and De Vos, W.M., 2011. Bifidobacterium population analysis in the infant gut by direct mapping of genomic hybridization patterns: potential for monitoring temporal development and effects of dietary regimens. Microbial Biotechnology 4: 417-427.
4. Clare, D. A., Catignani, G.L. and Swaisgood, H.E., 2003. Biodefense properties of milk: the role of antimicrobial proteins and peptides. Current Pharmaceutical Design 9: 1239-1255.
5. Dupont, C. and Clarke, A.J., 1991. Dependence of lysozyme-catalysed solubilization of proteus mirabilis peptidoglycan on the extent of O-acetylation. European Journal of Biochemistry / FEBS 195: 763-769.
6. Field, C.J., 2005. The immunological components of human milk and their effect on immune development in infants. Journal of Nutrition 135: 1-4.
7. Gagnon, M., Kheadr, E.E., Le Blay, G. and Fliss, I., 2004. In vitro inhibition of Escherichia coli O157:H7 by bifidobacterial strains of human origin. International Journal of Food Microbiology 92: 69-78.
8. Gavini, F., Delcenserie, V., Kopeinig, K.,pollinger, S., Beerens, H., Bonaparte, C. and Upmann, M., 2006. Bifidobacterium species isolated from animal feces and from beef and pork meat. Journal of Food Protection 69: 871-877.
9. Gavini, F., Pourcher, A. M., Neut, C., Monget, D., Romond, C., Oger, C. and Izard, D., 1991. Phenotypic differentiation of bifidobacteria of human and animal origins. International Journal of Systematic Bacteriology 41: 548-557.
10. Harmsen, H.J., Wildeboer-Veloo, A.C., Raangs, G.C., Wagendorp, A.A., Klijn, N., Bindels, J.G. and Welling, G.W., 2000. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. Journal of Pediatric Gastroenterology and Nutrition 30: 61-67.
11. Kitaoka, M., 2012. Bifidobacterial enzymes involved in the metabolism of human milk oligosaccharides. Advances in Nutrition 3: 422S-429S.
12. Kitaoka, M., Tian, J. and Nishimoto, M., 2005. Novel putative galactose operon involving lacto-N-biosephosphorylase in Bifidobacterium longum. Applied and Environmental Microbiology 71: 3158-3162.
13. Kobata, A., 2010. Structures and application of oligosaccharides in human milk. Proceedings of the Japan Academy Series B 86: 731-747.
14. Koh, D., Yang, Y., Khoo, L., Nyunt, S.Z., Ng, V. and Goh, C.L., 2004. Salivary immunoglobulin A and lysozyme inpatients with psoriasis. Annals of the Academy of Medicine, Singapore 33: 307-310.
15. Lönnerdal, B., 2003. Nutritional and physiologic significance of human milk proteins. American Journal of Clinical Nutrition 77: 1537S-1543S.
16. Masschalck, B. and Michiels, C. W., 2003. Antimicrobial properties of lysozyme in relation to foodborne vegetative bacteria. Critical Reviews in Microbiology 29: 191-214.
17. Matsuki, T. and Watanabe, K., 1999. Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted species-specific primers. Applied and Environmental Microbiology 65: 4506-4512.
18. Mattarelli, P., Crociani, F. and Biavati, B., 1997. Bactericidal activity ofpoly-D-lysine and lysozyme in Bifidobacterium globosum strains. Annali di Microbiologia ed Enzimologia 47: 185-191.
19. Milani, C., Lugli, G.A., Duranti, S., Turroni, F., Bottacini, F., Mangifesta, M. and Ventura, M., 2014. Genome encyclopaedia of type strains of the genus Bifidobacterium. Applied and Environmental Microbiology 80: 6290-6302.
20. Mitsuoka, T. and Kaneuchi, C., 1977. Ecology of the bifidobacteria. American Journal of Clinical Nutrition 30: 1799-1810.
21. Oda, H., Wakabayashi, H., Yamauchi, K. and Abe, F., 2014. Lactoferrin and bifidobacteria. Biometals 27: 915-922.
22. Op den Camp, H.J., Veerkamp, J.H., Oosterhof, A. and Van Halbeek, H., 1984. Structure of the lipoteichoic acids from Bifidobacterium bifidum spp. pennsylvanicum. Biochimica et Biophysica Acta 795: 301-313.
23. Rada, V., Splichal, I., Rockova, S., Grmanova, M. and Vlkova, E., 2010. Susceptibility of bifidobacteria to lysozyme as a possible selection criterion for probiotic bifidobacterial strains. Biotechnology Letters 32: 451-455.
24. Roberts, C.M., Fett, W.F., Osman, S.F., Wijey, C., O'Connor, J.V. and Hoover, D.G., 1995. Exopolysaccharide production by Bifidobacterium longum BB-79. Journal of Applied Bacteriology 78: 463-468.
25. Ročková, Š., Nevoral, J., Rada, V., Marsik, P., Sklenar, J., Hinkova, A. and Marounek, M., 2011. Factors affecting the growth of bifidobacteria in human milk. International Dairy Journal 21: 504-508.
26. Ročková, Š., Rada, V., Havlík, J., Švejstil, R., Vlková, E., Bunešová, V. and Profousová, I., 2013. Growth of bifidobacteria in mammalian milk. Czech Journal of Animal Science 58: 99-105.
27. Roger, L.C. and McCartney, A.L., 2010. Longitudinal investigation of the faecal microbiota of healthy full-term infants using fluorescence in situ hybridization and denaturing gradient gel electrophoresis. Microbiology 156: 3317-3328.
28. Roger, L.C., Costabile, A., Holland, D.T., Hoyles, L. and McCartney, A.L., 2010. Examination of faecal Bifidobacterium populations in breast- and formula-fed infants during the first 18 months of life. Microbiology 156: 3329-3341.
29. Sakata, S., Tonooka, T., Ishizeki, S., Takada, M., Sakamoto, M., Fukuyama, M. and Benno, Y., 2005. Culture-independent analysis of fecal microbiota in infants, with special reference to Bifidobacterium species. FEMS Microbiology Letters 243: 417-423.
30. Sela, D.A. and Mills, D.A., 2010. Nursing our microbiota: molecular linkages between bifidobacteria and milk oligosaccharides. Trends in Microbiology 18: 298-307.
31. Underwood, M.A., Kalanetra, K.M., Bokulich, N.A., Lewis, Z.T., Mirmiran, M., Tancredi, D.J. and Mills, D.A., 2013. A comparison of two probiotic strains of bifidobacteria in premature infants. Journal of Pediatrics 163: 1585-1591
32. Urashima, T., Asakuma, S., Leo, F., Fukuda, K., Messer, M. and Oftedal, O.T., 2012. The predominance of type I oligosaccharides is a feature specific to human breast milk. Advances in Nutrition 3: 473S-482S.
33. Xiao, J., Takahashi, S., Nishimoto, M., Odamaki, T., Yaeshima, T., Iwatsuki, K. and Kitaoka, M., 2010. Distribution of in vitro fermentation ability of lacto-N-biose I, a major building block of human milk oligosaccharides, in bifidobacterial strains. Applied and Environmental Microbiology 76: 54-59.